Novartis Pharmaceuticals Corporation recalls SANDIMMUNE Oral Solution (cyclosporine oral solution
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
- Products
-
- SANDIMMUNE Oral Solution (cyclosporine oral solution
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 6,997 bottles
- About this recall
- SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22